![](/img/cover-not-exists.png)
Combined lenalidomide, low-dose dexamethasone, and rituximab achieves durable responses in rituximab-resistant indolent and mantle cell lymphomas
Ahmadi, Tahamtan, Chong, Elise A., Gordon, Amanda, Aqui, Nicole A., Nasta, Sunita D., Svoboda, Jakub, Mato, Anthony R., Schuster, Stephen J.Volume:
120
Language:
english
Journal:
Cancer
DOI:
10.1002/cncr.28405
Date:
January, 2014
File:
PDF, 250 KB
english, 2014